2026 Annual Congress: Hematologic Malignancies
Ev sahibi National Comprehensive Cancer Network
- 18 – 19 September 2026
- New York Marriott Marquis, New York, United States of America
- Clinical MedicineHematoloji, Onkoloji ve Kanser Araştırmaları
Orada olacağınızı başkalarına bildirin. Bu işlem sizi etkinliğe kaydetmez.
Kayıt
Etkinlik sona erdiKayıt organizatör tarafından yapılıyor
Temel bilgiler
2026 Annual Congress: Hematologic Malignancies, National Comprehensive Cancer Network tarafından 18 – 19 Eylül 2026 tarihlerinde New York Marriott Marquis, New York, Amerika Birleşik Devletleri konumunda düzenlenen bir kongre etkinliğidir.
- Tarihler:
- 18 – 19 Eylül 2026
- Biçim:
- Hibrit (yüz yüze ve çevrim içi)
- Mekân:
- New York Marriott Marquis, New York, Amerika Birleşik Devletleri
- Konular:
- Haematology, Oncology & Cancer Research
- Organizatör:
- National Comprehensive Cancer Network
- Resmi web sitesi:
- nccn.org/hem
The Annual Congress: Hematologic Malignancies, organized by the National Comprehensive Cancer Network, is designed for the entire oncology team to explore treatment options and supportive care for various hematologic malignancies. Chaired by Andrew D. Zelenetz, MD, PhD, the event takes place in New York, New York, with virtual attendance options also available. It offers continuing education credits for physicians, PAs, nurses, pharmacists, and other oncology professionals.
Konular
- Advances in Leukemia Care
- Evolving Lymphoma Treatment Landscape
- Innovations in Cellular and Immune Therapies
- Treatment-Related Toxicity Monitoring and Management
- Plasma Cell Neoplasms
- Myeloid and Rare Hematologic Neoplasms
- Supportive Care and Survivorship
- Interprofessional Collaboration and Care
Kimler katılmalı
Designed for the Entire Oncology Team, including physicians, PAs, nurses, pharmacists, and other oncology professionals.
Düzenleme Kurulu
Chair: Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center.
Programdan öne çıkanlar
Programın tamamını görKonuşmacılar
26 konuşmacının tümünü görJohns Hopkins Kimmel Cancer Center
The Role of Clonal Hematopoiesis in Hematologic MalignanciesMass General Brigham Cancer Institute
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell LymphomaVanderbilt-Ingram Cancer Center
Oral Targeted Therapies in Relapsed/Refractory Acute Myeloid LeukemiaAbramson Cancer Center at the University of Pennsylvania
Current and Emerging Treatment Options for Peripheral T-Cell LymphomasCase Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic
Opening Remarks and Transforming the Management of Acute Lymphoblastic LeukemiaCleveland Clinic Taussig Cancer Institute
Evolving Treatment Strategies in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma and Closing Remarks
Organizatör ve iletişim
Ev sahibi kuruluş
National Comprehensive Cancer Networkİletişim
- E-posta:
- [email protected]
Reklam
İlgili etkinlikler
- 8th TIL Therapies Summit 2026Boston, Amerika Birleşik Devletleri17–19 Nov 2026
- International Kidney Cancer Symposium (IKCS): North America 2026Dallas, Amerika Birleşik Devletleri19–21 Nov 2026
- IASLC/ASCO 2026 North America Conference on Lung CancerScottsdale, Amerika Birleşik Devletleri4–6 Dec 2026
- San Antonio Breast Cancer Symposium® | SABCS 2026San Antonio, Amerika Birleşik Devletleri8–11 Dec 2026
- 68th ASH Annual Meeting and ExpositionNew Orleans, Amerika Birleşik Devletleri12–15 Dec 2026
- EORTC Leukemia Autumn Group Meeting 2026New Orleans, Amerika Birleşik Devletleri14 Dec 2026